A cell-impermeable diffusion chamber technique has been developed that lends itself to growth studies of Mycobacterium lepraemurium. This technique, in which the organism grows within macrophage cultures inside the chambers that are maintained on monolayer cultures of macrophages, provides a method for a strict in vitro evaluation of antileprosy drugs without the influence of a multiplicity of host factors. This system was used to compare the effect of three sulfone derivatives and rifampin on the growth ofM. lepraemurium within these diffusion chamber cultures. Two sulfones, 4,4'-diaminodiphenyl sulfone and 4,4'-diacetamidodiphenyl sulfone, as well as rifampin, suppressed the growth of M. lepraemurium, but monoacetyl sulfone 4-amino-4'acetamidodiphenyl sulfone had no effect. The results indicate that the diffusion chamber technique can be used to evaluate the inhibitory effect of antileprosy drugs on the growth ofM. lepraemurium. Also, the method provides for the first time a relatively rapid in vitro method for directly comparing the effects of drugs or their analogs when outside the metabolic influence of an animal host. This technique may be a useful tool for chemotherapy studies with other antileprosy compounds.
Successful growth of Mycobacterium lepraemurium has been achieved by use of a specialized diffusion chamber. Previous studies demonstrated that this acid-fast organism could be cultivated in these cell-impermeable porous chambers with a number of different host-chamber systems (10) . Maximum growth of organisms consisting of a 31-fold increase was obtained in chambers containing macrophages that were maintained for 50 days by intraperitoneal implantation in mice. In the same studies, diffusion chambers inoculated with mouse macrophages and M. lepraemurium and then maintained for 40 days on monolayer petri plate cultures of mouse macrophages exhibited ninefold increases in numbers of acid-fast bacilli (AFB). This in vitro method seemed to provide a system for testing the inhibitory activity of antileprosy drugs against M. lepraemurium in the absence of host factors such as absorption, metabolism, and excretion of the compounds.
The most effective widely used antileprosy drugs today are dapsone (4,4'-diaminodiphenyl sulfone, DDS), the repository form of DDS, acedapsone (4, 4 '-diacetamidodiphenyl sulfone, DADDS), and rifampin (7, 8, 11, 12, 14) . Studies in rats and humans have shown that monoacetyl DDS (4-amino-4'-acetamidodiphenyl sulfone, MADDS) is the principal circulatory metabolite of DDS and DADDS (3, 4, 7) , but no direct tests of the possible antileprotic activity of MADDS or DADDS have been performed with M. lepraemurium or M. leprae. Levy et al. (5) found that MADDS was equal in activity to DDS in mice infected with M. leprae, but the observation that the mice deacetylated MADDS completely to DDS made it impossible to decide whether MADDS exhibited inherent antileprotic activity.
To determine the relative inhibitory activities of DDS, MADDS, and DADDS on M. lepraemurium, we used the diffusion chamber system containing mouse macrophages and the AFB maintained on monolayer petri plate cultures of macrophages. With this system we were able to evaluate the effects of these sulfones on the growth of the organism without the influence of an animal host. Measurements of the sulfones in the cultures were carried out to examine whether they were altered during the incubation periods. In addition, the inhibitory effect of rifampin on (10) had demonstrated a ninefold increase of organisms during this time with this in vitro petri plate system. The chamber contents were harvested as previously described, and yields of AFB were determined from each replicate group for comparison of the total number and fold increase of M. lepraemurium from both treated and untreated chambers with those containing 0.3% Me2SO. In selected experiments, maintenance media from the petri plate cultures were analyzed for DDS and MADDS by the chromatographic-fluorometric procedure of Murray et al. (6) . Also, the viability and infectivity of the original AFB suspension used in each experiment were confirmed by inoculating 5 x 103 bacilli into mouse footpads.
Statistical methods. The consistency and reproducibility of the bacillary counts among replicate chambers within the same group already have been demonstrated (10 Fig. 1 . The average fold increase of AFB after treatment with increasing concentrations of each of the drugs showed that the effective concentrations of DDS occurred in the range from 0.04 to 4.0 ug/ml, those of DADDS were from 0.004 to 4.0 jig/ml, and those of rifampin were from 0.012 to 4.0 ,ug/ml. On the other hand, MADDS had no significant growth inhibitory effect. Also, the medium and Me2SO solvent controls showed no growth inhibition of bacilli within the chamber. yields of M. kepraemurium from the diffusion chambers. To evaluate the comparative activity of the three sulfones against growth of M. lepraemurium, we used molar equivalents of the sulfones in the diffusion chamber system. In this study, DDS was used at 1.2 ,ug/ml, MADDS at 1.5 ,ug/ml, and DADDS at 1.6 ,ug/ml. There was a 50% medium change in the petri plate cultures twice a week for six weekly cycles, and the harvested tissue culture fluids were analyzed for DDS and MADDS at each interval. Also, duplicate chambers were harvested every 2 weeks and the total number of AFB from each group was determined. The comparative effect of molar equivalents of DDS, MADDS, and DADDS on yields of M. lepraemurium harvested from the chambers every 2 weeks is shown in Fig. 3 . These results demonstrate that both DDS and DADDS significantly suppressed growth of the AFB, whereas molar equivalents of MADDS had no inhibitory effect. The chemical analyses for MADDS and DDS in the tissue culture media at the various sample times showed that no MADDS could be detected above the limit of sensitivity of the analytical method in the cultures containing added DDS (Table 2) . Similarly, essentially no DDS was found in the cultures containing added MADDS or DADDS, indicating that hydrolysis of the acetylated drugs to DDS was negligible. Thus, the inhibitory effects of the added DDS and DADDS must be due to the unaltered compounds, and MADDS was inherently inactive.
DISCUSSION
This study shows that the diffusion chamber technique is useful and can be applied for the in vitro evaluation of antileprosy drugs against M. lepraemurium. As illustrated in Fig. 1 , DDS, DADDS, and RMP consistently suppressed growth of the organism, permitting only a 2.5-to 3.5-fold increase of AFB in chambers at the end of 48 days; in contrast, both drug-free controls (Me2SO and media) and cultures containing MADDS gave a 6.0-to 7.0-fold increase of AFB. Although this suppressive effect of DDS, DADDS, and rifampin appeared small, it was consistently reproduced in five different experiments.
Similar results were obtained in the diffusion experiments illustrated in Fig. 2 . Both DDS and rifampin at concentrations of 1.2 ,tg/ml inhibited the growth of M. lepraemurium, whereas MADDS at the same level had no effect. Hence, the addition of drug inside the chamber did not significantly enhance its inhibitory effect.
In other comparative experiments, the growth of M. lepraemurium was inhibited by 1.2 ,ug of DDS or 1.6 ,ug of DADDS per ml, but MADDS showed no effect on the growth of the AFB at a molar equivalent concentration of 1.5 ,ug/ml. After 
